Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 20/20 | 0.84 |
| ▸ | ITGA4 | P13612 | 20/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4737746 | 0.94 | ITGB1 (0.82) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4736413 | 0.91 | ITGB1 (0.84) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4736681 | 0.91 | ITGB1 (1.00) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4735365 | 0.89 | ITGB1 (0.83) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4734053 | 0.88 | ITGB1 (0.84) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4734266 | 0.88 | ITGB1 (0.82) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4734306 | 0.88 | ITGB1 (0.64) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4783451 | 0.87 | ITGB1 (0.84) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4734606 | 0.87 | ITGB1 (0.83) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4732382 | 0.86 | ITGB1 (0.83) | ITGB1ITGA4CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008064830-A1 | BICYCLIC AND HETEROBICYCLIC DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR PHARMACEUTICAL USES | UCB PHARMA, S.A. (BE) | 2008-06-05 | — | — | WO | claimed |
| WO-2008064830-A1 | BICYCLIC AND HETEROBICYCLIC DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR PHARMACEUTICAL USES | UCB PHARMA, S.A. (BE) | 2008-06-05 | — | — | WO | disclosed |